Could GLP-1 Drugs Slow Aging? A New Trial Is Putting the Theory to the Test

Source: International Business Times

Researchers are beginning clinical trials aimed at determining whether drugs such as tirzepatide and semaglutide can influence some of the biological processes associated with getting older. Indranil Mukherjee/AFP via Getty Images Scientists are investigating whether the popular GLP-1 medications that are already reshaping the treatment of obesity and diabetes could have the potentially significant effect of slowing biological aging. Researchers are beginning clinical trials aimed at determining whether drugs such as tirzepatide and semaglutide can influence some of the biological processes associated with getting older, according to a report from ABC News' "Good Morning America.